These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2177333)

  • 21. [Antibiotics, developments and orientation].
    de Marie S; Verbrugh HA
    Ned Tijdschr Geneeskd; 1992 Apr; 136(14):673-8. PubMed ID: 1560853
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibiotics 1992: mechanism of resistance and its clinical relevance].
    Desgrandchamps D
    Schweiz Med Wochenschr; 1992 Feb; 122(8):247-56. PubMed ID: 1542777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain.
    Domínguez E; Zarazaga M; Sáenz Y; Briñas L; Torres C
    Microb Drug Resist; 2002; 8(4):321-7. PubMed ID: 12523629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An electrochemiluminescent method for the detection of beta-lactamases in microorganisms.
    Priano G; Ruzal SM; Battaglini F
    Anal Biochem; 2001 Mar; 290(2):379-82. PubMed ID: 11237344
    [No Abstract]   [Full Text] [Related]  

  • 25. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
    Mendonça N; Louro D; Castro AP; Diogo J; Caniça M
    J Antimicrob Chemother; 2006 May; 57(5):1014-6. PubMed ID: 16531434
    [No Abstract]   [Full Text] [Related]  

  • 26. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
    Castanheira M; Mendes RE; Woosley LN; Jones RN
    J Antimicrob Chemother; 2011 Jun; 66(6):1409-11. PubMed ID: 21421581
    [No Abstract]   [Full Text] [Related]  

  • 27. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.
    Sanders CC
    Annu Rev Microbiol; 1987; 41():573-93. PubMed ID: 3318679
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
    Hassan WM; Hashim A; Domany R
    Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transferrable broad-spectrum beta-lactam resistance in Klebsiella pneumoniae R-3455].
    Conde-Bonfil MC; Silva J; Ovando C; Becerra Z; González V; Fuchs Y
    Rev Latinoam Microbiol; 1993; 35(3):237-43. PubMed ID: 8047726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of quinolone resistance mechanisms and extended-spectrum β-lactamase production in Escherichia coli isolated from dogs.
    Meireles D; Leite-Martins L; Bessa LJ; Cunha S; Fernandes R; de Matos A; Manaia CM; Martins da Costa P
    Comp Immunol Microbiol Infect Dis; 2015 Aug; 41():43-8. PubMed ID: 25999092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic background of quinolone resistance in CTX-M-15-producing Klebsiella pneumonia and Escherichia coli strains in Tunisia.
    Abbassi MS; Ruiz E; Sáenz Y; Mechergui A; Ben Hassen A; Torres C
    J Chemother; 2010 Feb; 22(1):66-7. PubMed ID: 20227997
    [No Abstract]   [Full Text] [Related]  

  • 33. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From fluoroquinolones to 2-pyridones.
    Hooper DC
    Lancet; 1995 May; 345(8959):1192-3. PubMed ID: 7739303
    [No Abstract]   [Full Text] [Related]  

  • 36. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
    Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
    APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
    Giacometti A; Del Prete MS; Cirioni O; Izat MK; Balducci M; Cesarini AM; Scalise G
    J Chemother; 1995 Nov; 7 Suppl 4():76-7. PubMed ID: 8904115
    [No Abstract]   [Full Text] [Related]  

  • 39. Bacterial challenges and evolving antibacterial drug strategy.
    Watt B; Collee JG
    Postgrad Med J; 1992 Jan; 68(795):6-21. PubMed ID: 1561196
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M; Pous-Miralles G; Romera-Sastre G; Panisello-Bertomeu JM; Jardí-Baiges AM; Zarazoga-López J
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):477-81. PubMed ID: 9527373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.